JPL Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.75M Buy
34,075
+59
+0.2% +$8.26K 1.09% 30
2025
Q4
$4.18M Sell
34,016
-1,686
-5% -$205K 1.02% 40
2025
Q3
$3.96M Buy
35,702
+175
+0.5% +$19.9K 0.94% 42
2025
Q2
$3.94M Buy
35,527
+135
+0.4% +$14.4K 1.06% 42
2025
Q1
$3.97M Buy
35,392
+480
+1% +$49.5K 1.13% 32
2024
Q4
$3.22M Buy
+34,912
New +$3.14M 0.92% 47
2024
Q2
$1.74M Buy
25,419
+1,893
+8% +$126K 0.85% 57
2024
Q1
$1.72M Buy
23,526
+4,303
+22% +$331K 0.95% 52
2023
Q4
$1.56M Buy
+19,223
New +$1.5M 1.12% 38

Other funds holding GILD

JPL Wealth Management's GILD Position: Q1 2026 in Review

JPL Wealth Management increased its Gilead Sciences (GILD) stake by 0.17% in Q1 2026, buying an estimated $8.26K and bringing the position to 34,075 shares worth $4.75M. The position accounts for 1.09% of the portfolio, ranked #30.

JPL Wealth Management first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • JPL Wealth Management held 34,075 shares of Gilead Sciences worth $4.75M as of Q1 2026.
  • JPL Wealth Management bought 59 Gilead Sciences shares in Q1 2026, an estimated $8.26K.
  • Gilead Sciences made up 1.09% of JPL Wealth Management's portfolio in Q1 2026, its #30 holding.
  • JPL Wealth Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.